Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-21-002767
Filing Date
2021-08-18
Accepted
2021-08-18 07:01:07
Documents
31
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 COVER zk2126453.htm   iXBRL 6-K 17588
2 REGISTRANT'S PRESS RELEASE DATED AUGUST 18, 2021 exhibit_1.htm EX-99 415248
3 REGISTRANT'S CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS AS OF JUNE 30, exhibit_2.htm   iXBRL EX-99 602184
4 REGISTRANT'S OPERATING AND FINANCIAL REVIEW AS OF JUNE 30, 2021 AND FOR THE THRE exhibit_3.htm EX-99 169293
10 GRAPHIC image0.jpg GRAPHIC 5551
  Complete submission text file 0001178913-21-002767.txt   2519488

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE blrx-20210630.xsd EX-101.SCH 27035
6 XBRL CALCULATION FILE blrx-20210630_cal.xml EX-101.CAL 30408
7 XBRL DEFINITION FILE blrx-20210630_def.xml EX-101.DEF 41799
8 XBRL LABEL FILE blrx-20210630_lab.xml EX-101.LAB 211529
9 XBRL PRESENTATION FILE blrx-20210630_pre.xml EX-101.PRE 104406
11 EXTRACTED XBRL INSTANCE DOCUMENT zk2126453_htm.xml XML 177330
Mailing Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871
Business Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871 972-2-548-9100
BioLineRx Ltd. (Filer) CIK: 0001498403 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-35223 | Film No.: 211184988
SIC: 2834 Pharmaceutical Preparations